Literature DB >> 18437417

Cyclin D1 expression is induced by viral BARF1 and is overexpressed in EBV-associated gastric cancer.

Thorsten Wiech1, Elisabeth Nikolopoulos, Silke Lassman, Timo Heidt, Anja Schöpflin, Mario Sarbia, Martin Werner, Yuko Shimizu, Emna Sakka, Tadamasa Ooka, Axel zur Hausen.   

Abstract

Approximately 10% of gastric carcinomas (GC) worldwide are associated with Epstein-Barr virus (EBV). GC is one of the most frequent human malignancies associated with EBV. The latent expression of the EBV-oncogene BARF1 is restricted to epithelial malignancies. To investigate the underlying BARF1-related mechanisms of oncogenic epithelial transformation, we analyzed gene expression profiles of a BARF1-transfected epithelial (HaCaT+) and the corresponding BARF1-negative (HaCaT-) cell line by cDNA microarray analysis. Real-time PCR was performed to confirm the cDNA microarray results. In addition, immunohistochemistry and fluorescence in situ hybridization were performed on a tissue microarray of 181 GC including 11 EBV-associated GC. Among other genes cyclin D1 expression was significantly upregulated in HaCaT+ on the transcriptional and protein level. Cyclin D1 protein expression in GC revealed a significant overexpression of cyclin D1 in EBV-associated GC (p<0.012) but not in EBV-negative GC. Cyclin D1 FISH showed that cyclin D1 overexpression was not due to gene amplification in EBV-associated GC. Cyclin D1 is induced in HaCaT+ by BARF1 and is overexpressed in EBV-associated GC indicating an interaction of viral BARF1 and cyclin D1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18437417     DOI: 10.1007/s00428-008-0594-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  35 in total

1.  Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene.

Authors:  A zur Hausen; A A Brink; M E Craanen; J M Middeldorp; C J Meijer; A J van den Brule
Journal:  Cancer Res       Date:  2000-05-15       Impact factor: 12.701

2.  Hypothesis: a novel route for immortalization of epithelial cells by Epstein-Barr virus.

Authors:  Yanning Gao; Yong-Jie Lu; Shao-An Xue; Honglin Chen; Nina Wedderburn; Beverly E Griffin
Journal:  Oncogene       Date:  2002-01-24       Impact factor: 9.867

3.  Esophageal (Barrett's) adenocarcinoma is not associated with Epstein-Barr virus infection: an analysis of 162 cases.

Authors:  Mario Sarbia; Axel zur Hausen; Marcus Feith; Helene Geddert; Burkhard H A von Rahden; Rupert Langer; Claus von Weyhern; J Rüdiger Siewert; Heinz Höfler; Hubert J Stein
Journal:  Int J Cancer       Date:  2005-11-20       Impact factor: 7.396

4.  Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.

Authors:  Mee Soo Chang; Hye Seung Lee; Eun Ji Jung; Chul Woo Kim; Byung Lan Lee; Woo Ho Kim
Journal:  Int J Oncol       Date:  2005-11       Impact factor: 5.650

5.  Tauroursodesoxycholate-induced choleresis involves p38(MAPK) activation and translocation of the bile salt export pump in rats.

Authors:  A K Kurz; D Graf; M Schmitt; S Vom Dahl; D Häussinger
Journal:  Gastroenterology       Date:  2001-08       Impact factor: 22.682

6.  Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities.

Authors:  M Sarbia; M Stahl; U Fink; H Heep; P Dutkowski; R Willers; S Seeber; H E Gabbert
Journal:  Int J Cancer       Date:  1999-02-19       Impact factor: 7.396

7.  Alterations of the CCND1 and HER-2/neu (ERBB2) proteins in esophageal and gastric cancers.

Authors:  Lucimari Bizari; Aldenis Albanese Borim; Kátia Ramos Moreira Leite; Fernanda de Toledo Gonçalves; Patrícia Maluf Cury; Eloiza Helena Tajara; Ana Elizabete Silva
Journal:  Cancer Genet Cytogenet       Date:  2006-02

8.  Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance.

Authors:  Peng Gao; Geng-Yin Zhou; Yuan Liu; Jin-Song Li; Jun-Hui Zhen; Yin-Ping Yuan
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

9.  Alternate splicing produces a novel cyclin D1 transcript.

Authors:  D C Betticher; N Thatcher; H J Altermatt; P Hoban; W D Ryder; J Heighway
Journal:  Oncogene       Date:  1995-09-07       Impact factor: 9.867

10.  A transforming function of the BARF1 gene encoded by Epstein-Barr virus.

Authors:  M X Wei; T Ooka
Journal:  EMBO J       Date:  1989-10       Impact factor: 11.598

View more
  14 in total

1.  Epstein-Barr virus-encoded BARF1 promotes proliferation of gastric carcinoma cells through regulation of NF-κB.

Authors:  Mee Soo Chang; Dong Ha Kim; Jin Kyung Roh; Jaap M Middeldorp; Yang Soo Kim; Sunghan Kim; Seungbong Han; Chul Woo Kim; Byung Lan Lee; Woo Ho Kim; Jun Hee Woo
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

2.  EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.

Authors:  Helene Geddert; Axel zur Hausen; Helmut E Gabbert; Mario Sarbia
Journal:  Cell Oncol (Dordr)       Date:  2011-05-03       Impact factor: 6.730

Review 3.  The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.

Authors:  Chi Man Tsang; Sai Wah Tsao
Journal:  Virol Sin       Date:  2015-04-21       Impact factor: 4.327

4.  Analysis of cell cycle-related proteins in gastric intramucosal differentiated-type cancers based on mucin phenotypes: a novel hypothesis of early gastric carcinogenesis based on mucin phenotype.

Authors:  Tamotsu Sugai; Mitsunori Tsukahara; Masaki Endoh; Yoshihiro Shioi; Noriko Takebe; Yoshiharu Mue; Hiroo Matsushita; Minoru Toyota; Kazuyuki Suzuki
Journal:  BMC Gastroenterol       Date:  2010-06-07       Impact factor: 3.067

5.  Expression of BamHI-A Rightward Transcripts in Epstein-Barr Virus-Associated Gastric Cancers.

Authors:  Bo-Gun Jang; Eun Ji Jung; Woo Ho Kim
Journal:  Cancer Res Treat       Date:  2011-12-27       Impact factor: 4.679

Review 6.  BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator.

Authors:  Eveline K Hoebe; Tessa Y S Le Large; Astrid E Greijer; Jaap M Middeldorp
Journal:  Rev Med Virol       Date:  2013-08-31       Impact factor: 6.989

7.  Telomerase activity impacts on Epstein-Barr virus infection of AGS cells.

Authors:  Jürgen Rac; Florian Haas; Andrina Schumacher; Jaap M Middeldorp; Henri-Jacques Delecluse; Roberto F Speck; Michele Bernasconi; David Nadal
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

Review 8.  Epstein-barr virus in gastric carcinoma.

Authors:  Jun Nishikawa; Hironori Yoshiyama; Hisashi Iizasa; Yuichi Kanehiro; Munetaka Nakamura; Junichi Nishimura; Mari Saito; Takeshi Okamoto; Kouhei Sakai; Yutaka Suehiro; Takahiro Yamasaki; Atsunori Oga; Hideo Yanai; Isao Sakaida
Journal:  Cancers (Basel)       Date:  2014-11-07       Impact factor: 6.639

9.  Epstein-Barr Virus Gene BARF1 Expression is Regulated by the Epithelial Differentiation Factor ΔNp63α in Undifferentiated Nasopharyngeal Carcinoma.

Authors:  Eveline Hoebe; Coral Wille; Stacy Hagemeier; Shannon Kenney; Astrid Greijer; Jaap Middeldorp
Journal:  Cancers (Basel)       Date:  2018-03-17       Impact factor: 6.639

Review 10.  The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis.

Authors:  Abigail Morales-Sánchez; Ezequiel M Fuentes-Panana
Journal:  Cancers (Basel)       Date:  2018-03-30       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.